TrialThe British journal of ophthalmology2016

EP3/FP dual receptor agonist ONO-9054 administered morning or evening to patients with open-angle glaucoma or ocular hypertension: results of a randomised crossover study.

Michael S Berlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.